Statins: have we found the Holy Grail?

Swiss Med Wkly. 2012 Feb 3:142:w13515. doi: 10.4414/smw.2012.13515. eCollection 2012.


In coronary artery disease, cardiovascular risk factors are the main targets for primary and secondary prevention. Statins prevent cardiovascular events in patients at risk. However, despite the proven efficacy and safety of statins, relevant side effects exist and should be considered when treating patients.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / blood
  • Hyperlipidemias / drug therapy*
  • Lipids / blood*
  • Primary Prevention / methods*
  • Prognosis
  • Risk Factors
  • Secondary Prevention / methods*


  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids